key: cord-0721278-j6axuuth authors: Veronese, Sheila; Merigo, Flavia; Sbarbati, Andrea title: Did we forget the diffuse chemosensory system when studying COVID-19? date: 2021-01-08 journal: Immunol Lett DOI: 10.1016/j.imlet.2021.01.002 sha: 811e85a950b70d2a2047e30794fcf9415d3b2f2f doc_id: 721278 cord_uid: j6axuuth nan SARS-CoV-2 induces chemosensory disorder/dystonia. Eliezer et al. [1] reported the presence of a family of particular olfactory receptors that could be selectively altered by SARS-CoV-2, citing An and Liggett [2] , who identified these receptors in central cortical neurons, vascular muscle, and epithelium of the lower airways. This family of receptors resembles the diffuse chemosensory system (DCS), first described by Sbarbati et al. [3] . The DCS is an anatomical structure composed of solitary chemosensory/chemoreceptor cells (SCCs), which have phenotypic similarities to taste cells but are not aggregated into buds [4, 5] . Molecules and receptors thought to be present only in the taste system have also been described in organs of the respiratory and gastrointestinal systems [6] [7] [8] such as nose [9] , larynx [10] , trachea [11] [12] [13] , lungs [14] , pharynx [10] , and digestive system [15] . The SCCs located in different anatomical sites show some morphological differences, probably related to the multiple function that they perform in these sites in addition to their receptor function [8, [16] [17] [18] ]. An involvement of the olfactory and gustatory systems by COVID-19 has already been demonstrated [19] . For the sense of smell, general dysfunction of the combined threshold, discrimination and identification scores, and individual scores of both discrimination and identification was detected. The gustatory dysfunction was general and particularly significant for sweet and bitter taste [19] . Generally, cellular localisation of SARS-CoV-2 in the nasal cavity, using the viral spike protein receptor angiotensin-converting enzyme 2 (ACE2) as a marker, has only been reported considering the most representative cell types of the olfactory or respiratory mucosa, neglecting the presence of SCCs in these epithelia [20] . There are currently no studies in the literature that analyse this aspect. This deficiency may have repercussions on the understanding of the effects exerted by Covid-19 on epithelia, considering that epithelia are composed of heterogeneous cell populations, which with their different characteristics, properties, and functions contribute to creating a network of interconnected and cooperating cells. In this regard, different cell types have been shown to express bitter and sweet taste transduction pathways molecules and receptors in many peripheral sites, including respiratory and intestinal tissues [3, [21] [22] [23] [24] . Bitter and sweet receptors are G protein-coupled receptors (GPCRs), for which a role in the cellular entry mechanism of SARS-CoV-2 was already hypothesized [25] . Considering the COVID-19 symptoms, sputum [26, 27] is indicative of both the body's immune reaction to SARS-CoV-2 and DCS activation [28, 29] . The immune response leads to an increase in the production of mucus which, in the event of a strong immune reaction due, for example, to a viral attack, can degenerate into hypersecretion or dysfunction of the clearance system. DCS itself could contribute induce the immune response by triggering the mucus secretion to promote clearance [30] and/or by inducing dysfunction of the cilia motility [22] . Both hypersecretion and dysfunction of the clearance system could induce obstructive pulmonary diseases [31] [32] [33] . Furthermore, the paracrine action carried out by DCS [34] could also contribute to the development of interstitial pneumonia, through the recall of inflammatory cells and, therefore, of lymphocytes, in the interstitium. A type 2 immune response induced by DCS in the trachea has recently been hypothesized [35] . Descending in the gastrointestinal tract, DCS seems to play a fundamental role in the detection of ingested harmful drugs and toxins, thus initiating critical survival responses [36, 37] , responses consistent with the COVID-19 symptoms of diarrhoea, vomiting and abdominal pain [38, 39] . The excessive activation of the immune system results in an immunosuppression effect, particularly in the more severe COVID-19 forms [26, 27, 39] . Could DCS activation play a role in this last effect? Could the strong reaction of both systems create destructive interference, inducing an aberrant response to COVID-19 and exacerbating symptoms? These aspects have not been taken into account in recent studies concerning SARS-CoV-2 infection, suggesting that the involvement of DCS in the mechanisms of this novel coronavirus infection is underestimated. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors declare no conflict of interest. Sudden and complete olfactory loss function as a possible symptom of COVID-19 Taste and smell GPCRs in the lung: evidence for a previously unrecognized widespread chemosensory system The diffuse chemosensory system: exploring the iceberg toward the definition of functional roles Solitary chemosensory cells in mammals? The taste cell-related diffuse chemosensory system Oral and extraoral bitter taste receptors Taste receptor function Contents lists available at ScienceDirect Immunology Letters journal homepage Tuft cells: from the mucosa to the thymus Solitary chemoreceptor cells in the nasal cavity serve as sentinels of respiration Laryngeal chemosensory clusters Alpha-Gustducin immunoreactivity in the airways Cholinergic chemosensory cells in the trachea regulate breathing Chemosensory brush cells of the trachea. A stable population in a dynamic epithelium Expression of taste receptors in solitary chemosensory cells of rodent airways Bitter taste receptor mTas2r105 is expressed in small intestinal villus and crypts Nasal chemosensory cells use bitter taste signaling to detect irritants and bacterial signals Prokaryotic chemosensory systems Tuning tuft cells: new ligands and effector functions reveal tissue-specific function Comparison of COVID-19 and common cold chemosensory dysfunction ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs Taste isn't just for taste buds anymore Motile cilia of human airway epithelia are chemosensory Bitter tastants and artificial sweeteners activate a subset of epithelial cells in acute tissue slices of the rat trachea Glucose transporter/T1R3-expressing cells in rat tracheal epithelium COVID-19 transmission through host cell directed network of GPCR Clinical features and treatment of COVID-19 patients in northeast Chongqing Novel Coronavirus Outbreak Research Team, Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore Chemosensory cell-derived acetylcholine drives tracheal mucociliary clearance in response to virulence-associated formyl peptides Tracheal brush cells release acetylcholine in response to bitter tastants for paracrine and autocrine signaling Solitary chemoreceptor cells of Ciliata mustela (Gadidae, Teleostei) are tuned to mucoid stimuli Mucoactive agents for airway mucus hypersecretory diseases Airway mucus function and dysfunction Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases CCSP regulates cross talk between secretory cells and both ciliated cells and macrophages of the conducting airway The cysteinyl leukotriene 3 receptor regulates expansion of IL-25-producing airway brush cells leading to type 2 inflammation Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China